Case	case	O	O	O	O
report	report	O	O	O	O
:	:	O	O	O	O
Dexatrim	dexatrim	O	O	OTHERS	I
(	(	O	O	O	O
Phenylpropanolamine	phenylpropanolamine	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Phenylpropanolamine	phenylpropanolamine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
PPA	ppa	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
sympathetic	sympathetic	O	O	O	O
amine	amine	O	O	OTHERS	I
used	used	O	O	O	O
in	in	O	O	O	O
over-the-counter	over-the-counter	O	O	O	O
cold	cold	O	O	O	O
remedies	remedies	O	O	O	O
and	and	O	O	O	O
weight-control	weight-control	O	O	O	O
preparations	preparations	O	O	O	O
worldwide	worldwide	O	O	O	O
.	.	O	O	O	O

Its	its	O	O	O	O
use	use	O	O	O	O
has	has	O	O	O	O
been	been	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
hypertensive	hypertensive	O	DISEASE	OTHERS	I
episodes	episodes	O	O	O	O
and	and	O	O	O	O
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
strokes	strokes	O	DISEASE	OTHERS	I
in	in	O	O	O	O
younger	younger	O	O	O	O
women	women	O	O	O	O
.	.	O	O	O	O

Several	several	O	O	O	O
reports	reports	O	O	O	O
have	have	O	O	O	O
linked	linked	O	O	O	O
the	the	O	O	O	O
abuse	abuse	O	O	O	O
of	of	O	O	O	O
PPA	ppa	CHEMICALS	O	OTHERS	I
with	with	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
,	,	O	O	O	O
especially	especially	O	O	O	O
when	when	O	O	O	O
overdose	overdose	O	DISEASE	OTHERS	I
is	is	O	O	O	O
involved	involved	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
here	here	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
Dexatrim	dexatrim	O	O	OTHERS	I
(PPA)-induced	(ppa)-induced	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
young	young	O	O	O	O
woman	woman	O	O	O	O
who	who	O	O	O	O
was	was	O	O	O	O
using	using	O	O	O	O
it	it	O	O	O	O
at	at	O	O	O	O
recommended	recommended	O	O	O	O
doses	doses	O	O	O	O
for	for	O	O	O	O
weight	weight	O	O	O	O
control	control	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
addition	addition	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
review	review	O	O	O	O
the	the	O	O	O	O
7	7	O	O	O	O
other	other	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
PPA	ppa	CHEMICALS	O	OTHERS	I
related	related	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
that	that	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
so	so	O	O	O	O
far	far	O	O	O	O
.	.	O	O	O	O

Physicians	physicians	O	O	O	O
and	and	O	O	O	O
patients	patients	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
alert	alert	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
potential	potential	O	O	O	O
cardiac	cardiac	O	O	O	O
risk	risk	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
PPA	ppa	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
even	even	O	O	O	O
at	at	O	O	O	O
doses	doses	O	O	O	O
generally	generally	O	O	O	O
considered	considered	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
safe	safe	O	O	O	O
.	.	O	O	O	O

